CN Stock MarketDetailed Quotes

Tibet Duo Rui Pharmaceutical (301075)

Watchlist
  • 88.96
  • +5.17+6.17%
Market Closed May 19 15:00 CST
7.12BMarket Cap-70.77P/E (TTM)

Tibet Duo Rui Pharmaceutical (301075) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
Preparation55.36M35.91%
Raw material medicine49.74M32.26%
Intermediate38.96M25.27%
Other10.11M6.56%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Manufacturing industry101.16M65.61%
Other53.02M34.39%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Domestic154.11M99.96%
Abroad62.2K0.04%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
On May 19 Eastern Time, Trump warned that Iran might only have a negotiating window until Sunday or early next week, adding that 'it may be Show More